Yazama, Hiroaki <br/><br/>
Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide.  [electronic resource] 

 -  International journal of clinical oncology  Jun 2015 
 - 438-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1437-7772 
<br/><br/><label>Standard No.: </label>10.1007/s10147-014-0734-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Carcinoma, Squamous Cell--diet therapy<br/>Ceramides--biosynthesis<br/>Glucosylceramides--administration & dosage<br/>Head and Neck Neoplasms--diet therapy<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--biosynthesis<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Neovascularization, Pathologic--diet therapy<br/>Vascular Endothelial Growth Factor A--biosynthesis<br/>Vascular Endothelial Growth Factor Receptor-2--biosynthesis<br/>Xenograft Model Antitumor Assays